At the end of the interview, it became apparent that the current product loses its copyright, and will be competing with a cheaper, and presumably, equally effective, generic version. How interesting that the patent holder comes up with the new product at about the time the generic competition arrives at a cheaper price.
This is a very familiar story in the area of pharmaceuticals, the most profitable area of health care, and that is why my 45 minutes was worth $300, and taking care of undocumented patients without insurance, saving lives, is worth, to the state, practically nothing. So, I am volunteering myself as a very good interview to Big Pharma, and, yes, I'll take my cut in the good old American free enterprise way, but
don't expect me to use the product unless it does a different job, more effectively, than the least expensive, equivalent generic product. At least not until we have universal health insurance.
I feel lots better, thank you.